Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.890 AUD | -0.58% |
|
-1.01% | +3.45% |
Jul. 08 | Australia shares end flat after RBA stuns with steady rates | RE |
Jul. 02 | AMP Says to Defend Proceedings Filed by Dexus Unit Over Sale of New South Wales Shopping Center | MT |
Summary: DEXUS
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company's MSCI ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Highlights: DEXUS
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- With a P/E ratio at 13.38 for the current year and 9.34 for next year, earnings multiples are highly attractive compared with competitors.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
Weaknesses: DEXUS
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings Chart: DEXUS
Source: Surperformance
Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
---|---|---|---|---|---|
4.86B | |||||
11.2B | |||||
7.67B | |||||
5.67B | |||||
4.86B | |||||
- | 4.54B | ||||
4.4B | |||||
4.31B | |||||
4.23B | |||||
3.85B | |||||
Average | 5.56B | ||||
Weighted average by Cap. |
Investor (Composite)
Trader (Composite)
ESG MSCI
-
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
Valuation
P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- DXS Stock
- Ratings DEXUS
Select your edition
All financial news and data tailored to specific country editions